Researchers developed a dual-modality imaging system that combines high-resolution structural and chemical analysis with AI to improve skin cancer diagnosis.
Key Details
- 1The system merges line-field confocal optical coherence tomography (LC-OCT) with confocal Raman microspectroscopy.
- 2Over 330 nonmelanoma skin cancer samples were examined in a year-long clinical study.
- 3AI models trained on chemical spectra achieved classification accuracy of 0.95 for basal cell carcinoma and 0.92 for both basal and squamous cell carcinoma.
- 4The approach allows targeted, noninvasive analysis of suspicious skin structures at cellular and molecular levels.
Why It Matters
This innovation promises less invasive, more accurate skin cancer diagnosis by combining structural and biochemical imaging with AI classification, potentially reducing reliance on biopsies and improving patient outcomes.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.